doi:10.1093/cid/ciu065 Dinleyici EC, Eren M, Dogan N, Reyhanioglu S, Yargic ZA, Vandenplas Y
Free Radic Res 53(2):210225 Rahim NA, Jantan I, Said MM, Jalil J, Abd Razak AF, Husain K (2021) Anti-allergic rhinitis effects of medicinal plants and their bioactive metabolites via suppression of the immune system: a mechanistic review
nej.md/3LAr7zx Original Article: Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity nej.md/449Ok27 Editorial: Next Chapter for Weight Control Small-Molecule GLP-1 Receptor Agonists
A trained clinician should demonstrate proper injection technique to minimize local irritation
Kesimer M, Ford AA, Ceppe A, Radicioni G, Cao R, Davis CW, Doerschuk CM, Alexis NE, Anderson WH, Henderson AG, et al
Claimed pharmaceutical benefits Out of all patients initiated on GLP-1 RAs between 2019 and 2023, nearly 80% had their first prescription dispensed within the pharmaceutical benefits